Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novartis/Chiron Deal To Close April 20

This article was originally published in The Pink Sheet Daily

Executive Summary

Novartis' acquisition of Chiron is set to close on April 20, the firms said April 19

You may also be interested in...



Vasella Knocks AstraZeneca Acquisition Rumor

Novartis CEO Daniel Vasella dismissed rumors that the firm is considering acquisition of rival drug maker AstraZeneca July 17

Novartis’ Diovan Growth Bolstered By Awareness Program, Part D

The company reported double-digit sales growth for its top three products in the second quarter.

Vasella Knocks AstraZeneca Acquisition Rumor

Novartis CEO Daniel Vasella dismissed rumors that the firm is considering acquisition of rival drug maker AstraZeneca July 17

Related Content

Topics

UsernamePublicRestriction

Register

ID007083

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel